Business
INVO Bioscience and NAYA Biosciences Announce Merger and Board Appointment, Stock Soars
In a significant move aimed at advancing global access to advanced fertility treatment and breakthrough therapies in oncology and regenerative medicine, INVO Bioscience, and NAYA...
Stocks React to Powell’s Hawkish Tone, Open Higher
In a market response to Federal Reserve Chair Jerome Powell’s more assertive stance, stocks opened higher on Friday, terminating the longest winning streak of the...
Wall Street Faces Volatility After Unexpected Treasury Auction Outcome
Wall Street stocks experienced a notable slump on Thursday as yields on US government bonds surged following a Treasury auction that fell short of investor...
Cutera Inc Faces Significant Decline in Q3 2023 Financial Results, Stock Dips
On November 8, 2023, Cutera Inc, a prominent player in the aesthetic and dermatology solutions industry, unveiled preliminary financial results for the third quarter (Q3)...
OncoCyte Corp Reveals Strong Q3 2023 Financial Results and Strategic Plans for 2024
OncoCyte Corp, a leading precision diagnostics company, unveiled its financial results for the third quarter (Q3) ending on September 30, 2023. The company is gearing...
Deal with Actors Boosts Hollywood Studios’ Prospects for Production Restart
Hollywood studios’ investors celebrated Thursday following the announcement of a provisional deal with actors, signaling a potential resurgence in movie and television production that had...
Near Intelligence Inc’s Stock Soars, Trading at $0.26
Near Intelligence Inc., a leading provider of privacy-safe global consumer behavior data for informed business decisions, experienced a surprising surge in its stock value on...
Lantern Pharma Q3 Results: Steady Financial Gains, Stock Jumps
Lantern Pharma, a pioneering artificial intelligence (“AI”) company specializing in targeted and transformative cancer therapies, unveiled its financial results for the third quarter (Q3) ending...
Micromobility.com Secures Nasdaq Extension, Bolsters Future Prospects
Micromobility.com, a frontrunner in pioneering urban transportation solutions, announced today that it has been granted an extension by the Nasdaq Hearings Panel to maintain its...
Tempest Therapeutics Unveils Strong Q3 Results, Extending Cash Runway into 2025, Stock Soars
Tempest Therapeutics, a clinical-stage oncology company specializing in the development of innovative therapeutics combining targeted and immune-mediated mechanisms, announced its financial results for the third...